Individual cognitive stimulation therapy for people with intellectual disability and dementia: protocol of a feasibility randomised controlled trial
- PMID: 30530576
- PMCID: PMC6292419
- DOI: 10.1136/bmjopen-2018-022136
Individual cognitive stimulation therapy for people with intellectual disability and dementia: protocol of a feasibility randomised controlled trial
Abstract
Introduction: Cognitive stimulation therapy (CST) is a psychosocial intervention for dementia. Group CST is effective in reducing cognitive decline and improving quality of life in patients with dementia. There is some evidence that individual CST (iCST) may be beneficial in reducing cognitive decline. People with intellectual disability (ID) have an increased risk of dementia. However, there are no published studies of CST in people with ID and dementia. This protocol describes the feasibility and acceptability of a randomised controlled trial of iCST delivered by carers to people with ID and dementia, compared with treatment as usual (TAU). The results of this study will inform the design of a future definitive randomised controlled trial.
Methods and analysis: The iCST intervention has been adapted for this trial. Forty dyads (individuals with ID and their carer) will be randomised to either iCST or TAU. The manualised intervention comprises 40 iCST sessions delivered by a carer for 30 min, twice a week, over 20 weeks. The primary outcome will be process measures assessing the feasibility and acceptability of the intervention and trial procedures. The secondary outcome will be changes in the scores of outcome measures (cognition, functional ability and quality of life in individuals with ID, and caregiver burden, competence in managing dementia, and anxiety and depression in carers). Data will be collected at baseline, 11 weeks and at 21 weeks. A process evaluation will examine adherence to iCST and will include qualitative interviews with participants to identify aspects of the intervention that were or were not successful.
Ethics and dissemination: The study has received ethical approval. The results of the study will be presented at conferences and submitted to a peer reviewed journal.
Trial registration number: ISRCTN18312288; Pre-results.
Keywords: cognition; cognitive stimulation therapy; dementia; funtioning; intellectual disability.
© Author(s) (or their employer(s)) 2018. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures

Similar articles
-
Individual cognitive stimulation therapy for dementia: a clinical effectiveness and cost-effectiveness pragmatic, multicentre, randomised controlled trial.Health Technol Assess. 2015 Aug;19(64):1-108. doi: 10.3310/hta19640. Health Technol Assess. 2015. PMID: 26292178 Free PMC article. Clinical Trial.
-
Individual cognitive stimulation therapy (iCST) for people with intellectual disability and dementia: a feasibility randomised controlled trial.Aging Ment Health. 2022 Apr;26(4):698-708. doi: 10.1080/13607863.2020.1869180. Epub 2021 Jan 4. Aging Ment Health. 2022. PMID: 33393364 Clinical Trial.
-
The impact of individual Cognitive Stimulation Therapy (iCST) on cognition, quality of life, caregiver health, and family relationships in dementia: A randomised controlled trial.PLoS Med. 2017 Mar 28;14(3):e1002269. doi: 10.1371/journal.pmed.1002269. eCollection 2017 Mar. PLoS Med. 2017. PMID: 28350796 Free PMC article. Clinical Trial.
-
Supporting advanced dementia in people with Down syndrome and other intellectual disability: consensus statement of the International Summit on Intellectual Disability and Dementia.J Intellect Disabil Res. 2018 Jul;62(7):617-624. doi: 10.1111/jir.12500. Epub 2018 May 20. J Intellect Disabil Res. 2018. PMID: 29781149
-
Effectiveness of Cognitive Stimulation Therapy (CST) for mild to moderate dementia: A systematic literature review and meta-analysis of randomised control trials using the original CST protocol.Ageing Res Rev. 2024 Jun;97:102312. doi: 10.1016/j.arr.2024.102312. Epub 2024 Apr 16. Ageing Res Rev. 2024. PMID: 38636561
Cited by
-
Cognitive Stimulation Therapy as an Adjunctive Treatment for Mild to Moderate Dementia.Ann Indian Acad Neurol. 2023 Jul-Aug;26(4):345-346. doi: 10.4103/aian.aian_287_23. Epub 2023 Jun 12. Ann Indian Acad Neurol. 2023. PMID: 37970269 Free PMC article. No abstract available.
-
Self-care research: Where are we now? Where are we going?Int J Nurs Stud. 2021 Apr;116:103402. doi: 10.1016/j.ijnurstu.2019.103402. Epub 2019 Aug 23. Int J Nurs Stud. 2021. PMID: 31630807 Free PMC article.
-
Cognitive Therapy for Children with Intellectual Disabilities: A New Look at Social Adaptation Skills and Interpersonal Relationships.Occup Ther Int. 2023 Apr 3;2023:6466836. doi: 10.1155/2023/6466836. eCollection 2023. Occup Ther Int. 2023. PMID: 37051114 Free PMC article. Clinical Trial.
-
Activities of Daily Living and Associated Costs in the Most Widespread Neurodegenerative Diseases: A Systematic Review.Clin Interv Aging. 2020 Oct 2;15:1841-1862. doi: 10.2147/CIA.S264688. eCollection 2020. Clin Interv Aging. 2020. PMID: 33061334 Free PMC article.
-
Effects of creative expression therapy on Chinese elderly patients with dementia: an exploratory randomized controlled trial.Neuropsychiatr Dis Treat. 2019 Jul 30;15:2171-2180. doi: 10.2147/NDT.S200045. eCollection 2019. Neuropsychiatr Dis Treat. 2019. PMID: 31440055 Free PMC article.
References
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Medical